Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111203276B reveals a manganese-catalyzed hydrosilylation method for high-purity chiral silanes, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN115197271B discloses efficient synthesis of chiral selenium/sulfur ligands. Enables cost-effective production of high-purity pharmaceutical intermediates with improved catalytic activity.
Patent CN101400632A details novel Ruthenium-P-N complexes for high-ee ketone hydrogenation, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN106046065B details a high-yield synthesis of chiral ferrocene ligands. Discover cost-effective manufacturing and reliable supply chain solutions for asymmetric catalysis.
Patent CN109535018B details a redox-neutral cross-coupling method for high-purity binaphtholamine derivatives, offering significant cost reduction in chiral ligand manufacturing.
Patent CN106831862A introduces a novel chiral bridged ligand enhancing enantioselectivity in Suzuki reactions, offering cost-effective purification and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN111732542A details a novel synthesis for chiral NN-dioxide ligands featuring axial binaphthyl skeletons, offering enhanced stereocontrol and scalable manufacturing for fine chemical applications.
Patent CN111732542A details a novel chiral ligand synthesis. We offer scalable manufacturing, cost reduction in asymmetric catalysis, and reliable supply chain solutions.
Patent CN111892559B details a high-yield asymmetric epoxidation of chalcones using chiral TADDOL ligands and rare earth metal amides, offering significant cost reduction in chiral epoxide manufacturing.
Patent CN115340572B discloses X-Binaphane, a novel xanthene-based bisphosphine ligand enabling high stereoselectivity in API manufacturing with scalable synthesis.
Novel synthesis route for Efavirenz chiral ligand from L-Alanine. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Patent CN120965569A reveals double five-membered ring ligands enhancing stereoselectivity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN111217848A details novel silicon-centered spiro ligands enabling high-yield asymmetric synthesis. Discover supply chain advantages and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108409802B details a high-efficiency iridium-catalyzed asymmetric hydrogenation route for producing high-purity chiral ferrocene amines with significant cost advantages.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Patent CN113135955B discloses a scalable route for C2 symmetric Trost ligands, offering cost reduction in asymmetric catalysis manufacturing and reliable supply.
Novel TiCl4-catalyzed asymmetric cyclization for high-purity spiroindane intermediates. Eliminates resolution steps, ensuring cost-effective supply for chiral ligand manufacturing.
Patent CN105712889B reveals a cost-effective route for Ticagrelor intermediates. Discover kinetic resolution benefits and supply chain advantages for pharmaceutical manufacturing.